Soleno Therapeutics Ownership 2024 | Who Owns Soleno Therapeutics Now?
Institutional Ownership
119.63%
Insider Ownership
3.38%
Retail Ownership
-23.01%
Institutional Holders
119.00
Soleno Therapeutics Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| VIVO CAPITAL, LLC | 20.21% | 27.58% | 7,316,851 | -1,101,242 | -13.08% | 298,527,521 | Jun 30, 2024 |
| CARLYLE GROUP INC. | 11.24% | 15.80% | 4,071,562 | - | - | 166,364,023 | Jun 30, 2024 |
| JANUS HENDERSON GROUP PLC | 9.28% | 0.07% | 3,358,873 | 488,062 | 17.00% | 137,135,124 | Jun 30, 2024 |
| PERCEPTIVE ADVISORS LLC | 8.85% | 3.11% | 3,204,976 | 130,434 | 4.24% | 130,763,021 | Jun 30, 2024 |
| NANTAHALA CAPITAL MANAGEMENT, LLC | 8.51% | 7.40% | 3,082,107 | 671,728 | 27.87% | 125,749,966 | Jun 30, 2024 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 7.88% | 0.22% | 2,854,094 | 910,574 | 46.85% | 116,447,035 | Jun 30, 2024 |
| AVORO CAPITAL ADVISORS LLC | 5.78% | 1.14% | 2,091,666 | 466,666 | 28.72% | 85,339,973 | Jun 30, 2024 |
| BLACKROCK INC. | 5.15% | 0.00% | 1,863,454 | 1,537,156 | 471.09% | 76,028,923 | Jun 30, 2024 |
| VANGUARD GROUP INC | 4.15% | 0.00% | 1,502,753 | 533,098 | 54.98% | 61,312,322 | Jun 30, 2024 |
| COMMODORE CAPITAL LP | 3.94% | 3.97% | 1,425,000 | 1,255,467 | 740.54% | 58,140,000 | Jun 30, 2024 |
| VESTAL POINT CAPITAL, LP | 3.31% | 3.65% | 1,200,000 | -50,000 | -4.00% | 48,960,000 | Jun 30, 2024 |
| STATE STREET CORP | 2.76% | 0.00% | 1,000,136 | 29,566 | 3.05% | 40,805,549,000 | Jun 30, 2024 |
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 2.42% | 1.67% | 875,667 | - | - | 35,727,214 | Jun 30, 2024 |
| ASSENAGON ASSET MANAGEMENT S.A. | 2.02% | 0.07% | 729,841 | 729,841 | 100.00% | 29,777,513 | Jun 30, 2024 |
| SOFINNOVA INVESTMENTS, INC. | 1.53% | 1.18% | 554,359 | 403,584 | 267.67% | 22,617,847 | Jun 30, 2024 |
| HOLOCENE ADVISORS, LP | 1.48% | 0.09% | 536,451 | 536,451 | 100.00% | 21,887,201 | Jun 30, 2024 |
| SAMLYN CAPITAL, LLC | 1.38% | 0.34% | 501,049 | 282,122 | 128.87% | 20,442,799 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.35% | 0.00% | 489,107 | 322,086 | 192.84% | 19,959,634 | Jun 30, 2024 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 1.32% | 0.00% | 477,852 | 325,232 | 213.10% | 19,497,000 | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | 1.27% | 0.01% | 458,520 | 366,295 | 397.18% | 18,707,616 | Jun 30, 2024 |
Soleno Therapeutics's largest institutional shareholder is VIVO CAPITAL, LLC, holding 20.21% of the company's total share outstanding, currently valued at $298.53M. The top 10 institutional shareholders own together 84.98% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| VIVO CAPITAL, LLC | 20.21% | 27.58% | 7,316,851 | -1,101,242 | -13.08% | 298,527,521 | Jun 30, 2024 |
| CARLYLE GROUP INC. | 11.24% | 15.80% | 4,071,562 | - | - | 166,364,023 | Jun 30, 2024 |
| NANTAHALA CAPITAL MANAGEMENT, LLC | 8.51% | 7.40% | 3,082,107 | 671,728 | 27.87% | 125,749,966 | Jun 30, 2024 |
| ALLY BRIDGE GROUP (NY) LLC | 0.79% | 6.96% | 286,162 | -50,324 | -14.96% | 11,675,410 | Jun 30, 2024 |
| COMMODORE CAPITAL LP | 3.94% | 3.97% | 1,425,000 | 1,255,467 | 740.54% | 58,140,000 | Jun 30, 2024 |
| GHOST TREE CAPITAL, LLC | 0.83% | 3.83% | 300,000 | 100,000 | 50.00% | 12,240,000 | Jun 30, 2024 |
| VESTAL POINT CAPITAL, LP | 3.31% | 3.65% | 1,200,000 | -50,000 | -4.00% | 48,960,000 | Jun 30, 2024 |
| ALTIUM CAPITAL MANAGEMENT LP | 0.59% | 3.54% | 212,909 | 60,000 | 39.24% | 8,686,687 | Jun 30, 2024 |
| IKARIAN CAPITAL, LLC | 1.23% | 3.17% | 445,451 | -119,960 | -21.22% | 18,174,401 | Jun 30, 2024 |
| PERCEPTIVE ADVISORS LLC | 8.85% | 3.11% | 3,204,976 | 130,434 | 4.24% | 130,763,021 | Jun 30, 2024 |
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 2.42% | 1.67% | 875,667 | - | - | 35,727,214 | Jun 30, 2024 |
| SOFINNOVA INVESTMENTS, INC. | 1.53% | 1.18% | 554,359 | 403,584 | 267.67% | 22,617,847 | Jun 30, 2024 |
| AVORO CAPITAL ADVISORS LLC | 5.78% | 1.14% | 2,091,666 | 466,666 | 28.72% | 85,339,973 | Jun 30, 2024 |
| ARTIA GLOBAL PARTNERS LP | 0.26% | 0.74% | 94,424 | 53,500 | 130.73% | 3,852,499 | Jun 30, 2024 |
| EMERALD MUTUAL FUND ADVISERS TRUST | 0.67% | 0.52% | 241,099 | 9,338 | 4.03% | 9,836,839 | Jun 30, 2024 |
| EMERALD ADVISERS, LLC | 0.81% | 0.50% | 293,328 | -7,048 | -2.35% | 11,967,782 | Jun 30, 2024 |
| CHECKPOINT CAPITAL L.P. | 0.05% | 0.48% | 19,695 | 19,695 | 100.00% | 803,556 | Jun 30, 2024 |
| SAMLYN CAPITAL, LLC | 1.38% | 0.34% | 501,049 | 282,122 | 128.87% | 20,442,799 | Jun 30, 2024 |
| ADAR1 CAPITAL MANAGEMENT, LLC | 0.11% | 0.31% | 39,929 | 39,929 | 100.00% | 1,629,103 | Jun 30, 2024 |
| 683 CAPITAL MANAGEMENT, LLC | 0.19% | 0.22% | 70,000 | -8,000 | -10.26% | 2,856,000 | Jun 30, 2024 |
The largest Soleno Therapeutics shareholder by % of total assets is VIVO CAPITAL, LLC. The company owns 7.32M shares of Soleno Therapeutics (SLNO), representing 27.58% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| BLACKROCK INC. | 5.15% | 0.00% | 1,863,454 | 1,537,156 | 471.09% | 76,028,923 | Jun 30, 2024 |
| COMMODORE CAPITAL LP | 3.94% | 3.97% | 1,425,000 | 1,255,467 | 740.54% | 58,140,000 | Jun 30, 2024 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 7.88% | 0.22% | 2,854,094 | 910,574 | 46.85% | 116,447,035 | Jun 30, 2024 |
| ASSENAGON ASSET MANAGEMENT S.A. | 2.02% | 0.07% | 729,841 | 729,841 | 100.00% | 29,777,513 | Jun 30, 2024 |
| NANTAHALA CAPITAL MANAGEMENT, LLC | 8.51% | 7.40% | 3,082,107 | 671,728 | 27.87% | 125,749,966 | Jun 30, 2024 |
| HOLOCENE ADVISORS, LP | 1.48% | 0.09% | 536,451 | 536,451 | 100.00% | 21,887,201 | Jun 30, 2024 |
| VANGUARD GROUP INC | 4.15% | 0.00% | 1,502,753 | 533,098 | 54.98% | 61,312,322 | Jun 30, 2024 |
| JANUS HENDERSON GROUP PLC | 9.28% | 0.07% | 3,358,873 | 488,062 | 17.00% | 137,135,124 | Jun 30, 2024 |
| AVORO CAPITAL ADVISORS LLC | 5.78% | 1.14% | 2,091,666 | 466,666 | 28.72% | 85,339,973 | Jun 30, 2024 |
| SOFINNOVA INVESTMENTS, INC. | 1.53% | 1.18% | 554,359 | 403,584 | 267.67% | 22,617,847 | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | 1.27% | 0.01% | 458,520 | 366,295 | 397.18% | 18,707,616 | Jun 30, 2024 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 1.32% | 0.00% | 477,852 | 325,232 | 213.10% | 19,497,000 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.35% | 0.00% | 489,107 | 322,086 | 192.84% | 19,959,634 | Jun 30, 2024 |
| SAMLYN CAPITAL, LLC | 1.38% | 0.34% | 501,049 | 282,122 | 128.87% | 20,442,799 | Jun 30, 2024 |
| WOODLINE PARTNERS LP | 0.88% | 0.12% | 319,205 | 212,745 | 199.84% | 13,023,564 | Jun 30, 2024 |
| CAPTION MANAGEMENT, LLC | 0.59% | 0.14% | 215,200 | 155,200 | 258.67% | 8,780,160 | Jun 30, 2024 |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 0.40% | 0.06% | 145,110 | 145,110 | 100.00% | 5,920,488 | Jun 30, 2024 |
| PERCEPTIVE ADVISORS LLC | 8.85% | 3.11% | 3,204,976 | 130,434 | 4.24% | 130,763,021 | Jun 30, 2024 |
| GHOST TREE CAPITAL, LLC | 0.83% | 3.83% | 300,000 | 100,000 | 50.00% | 12,240,000 | Jun 30, 2024 |
| PICTET ASSET MANAGEMENT HOLDING SA | 1.19% | 0.02% | 431,760 | 97,908 | 29.33% | 17,615,808 | Jun 30, 2024 |
As of Jun 30 2024, Soleno Therapeutics's largest institutional buyer is BLACKROCK INC.. The company purchased 1.54M stocks of SLNO, valued at $76.03M.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| VIVO CAPITAL, LLC | 20.21% | 27.58% | 7,316,851 | -1,101,242 | -13.08% | 298,527,521 | Jun 30, 2024 |
| INVESCO LTD. | 0.03% | 0.00% | 11,032 | -308,998 | -96.55% | 450,106 | Jun 30, 2024 |
| MARSHALL WACE, LLP | - | - | - | -176,237 | -100.00% | - | Jun 30, 2024 |
| IKARIAN CAPITAL, LLC | 1.23% | 3.17% | 445,451 | -119,960 | -21.22% | 18,174,401 | Jun 30, 2024 |
| STEMPOINT CAPITAL LP | - | - | - | -115,833 | -100.00% | - | Jun 30, 2024 |
| IKARIAN CAPITAL, LLC | - | - | - | -81,100 | -100.00% | - | Jun 30, 2024 |
| EAM INVESTORS, LLC | - | - | - | -64,411 | -100.00% | - | Jun 30, 2024 |
| RAFFERTY ASSET MANAGEMENT, LLC | 0.15% | 0.01% | 53,937 | -52,207 | -49.19% | 2,200,630 | Jun 30, 2024 |
| ALLY BRIDGE GROUP (NY) LLC | 0.79% | 6.96% | 286,162 | -50,324 | -14.96% | 11,675,410 | Jun 30, 2024 |
| VESTAL POINT CAPITAL, LP | 3.31% | 3.65% | 1,200,000 | -50,000 | -4.00% | 48,960,000 | Jun 30, 2024 |
| BOOTHBAY FUND MANAGEMENT, LLC | 0.29% | 0.10% | 104,020 | -28,011 | -21.22% | 4,244,016 | Jun 30, 2024 |
| FARALLON CAPITAL MANAGEMENT LLC | - | - | - | -27,750 | -100.00% | - | Jun 30, 2024 |
| ALLIANZ ASSET MANAGEMENT GMBH | - | - | - | -25,100 | -100.00% | - | Jun 30, 2024 |
| QUBE RESEARCH & TECHNOLOGIES LTD | 0.16% | 0.00% | 56,316 | -22,184 | -28.26% | 2,297,693 | Jun 30, 2024 |
| BOOTHBAY FUND MANAGEMENT, LLC | - | - | - | -21,600 | -100.00% | - | Jun 30, 2024 |
| UBS GROUP AG | 0.09% | 0.00% | 33,950 | -19,855 | -36.90% | 1,385,160 | Jun 30, 2024 |
| SQUAREPOINT OPS LLC | - | - | - | -14,580 | -100.00% | - | Jun 30, 2024 |
| EXODUSPOINT CAPITAL MANAGEMENT, LP | - | - | - | -14,206 | -100.00% | - | Jun 30, 2024 |
| CANNON GLOBAL INVESTMENT MANAGEMENT, LLC | - | - | - | -11,800 | -100.00% | - | Jun 30, 2024 |
| MORGAN STANLEY | 0.26% | 0.00% | 92,977 | -11,026 | -10.60% | 3,793,462 | Jun 30, 2024 |
As of Jun 30 2024, Soleno Therapeutics's biggest institutional seller is VIVO CAPITAL, LLC. The company sold -1.10M shares of SLNO, valued at $298.53M.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| ASSENAGON ASSET MANAGEMENT S.A. | 2.02% | 0.07% | 729,841 | 729,841 | 100.00% | 29,777,513 | Jun 30, 2024 |
| HOLOCENE ADVISORS, LP | 1.48% | 0.09% | 536,451 | 536,451 | 100.00% | 21,887,201 | Jun 30, 2024 |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 0.40% | 0.06% | 145,110 | 145,110 | 100.00% | 5,920,488 | Jun 30, 2024 |
| POLAR ASSET MANAGEMENT PARTNERS INC. | 0.21% | 0.06% | 74,500 | 74,500 | 100.00% | 3,039,600 | Jun 30, 2024 |
| NUVEEN ASSET MANAGEMENT, LLC | 0.16% | 0.00% | 59,478 | 59,478 | 100.00% | 2,426,702 | Jun 30, 2024 |
| NORGES BANK | 0.16% | 0.00% | 57,770 | 57,770 | 100.00% | 2,357,016 | Jun 30, 2024 |
| ADAR1 CAPITAL MANAGEMENT, LLC | 0.11% | 0.31% | 39,929 | 39,929 | 100.00% | 1,629,103 | Jun 30, 2024 |
| HUDSON BAY CAPITAL MANAGEMENT LP | 0.08% | 0.01% | 30,000 | 30,000 | 100.00% | 1,224,000 | Jun 30, 2024 |
| RHUMBLINE ADVISERS | 0.08% | 0.00% | 29,144 | 29,144 | 100.00% | 1,189,071 | Jun 30, 2024 |
| ALLIANCEBERNSTEIN L.P. | 0.07% | 0.00% | 24,610 | 24,610 | 100.00% | 1,004,088 | Jun 30, 2024 |
| ALPINE GLOBAL MANAGEMENT, LLC | 0.06% | 0.15% | 20,824 | 20,824 | 100.00% | 849,619 | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | 0.06% | 0.00% | 20,000 | 20,000 | 100.00% | 816,000 | Jun 30, 2024 |
| CHECKPOINT CAPITAL L.P. | 0.05% | 0.48% | 19,695 | 19,695 | 100.00% | 803,556 | Jun 30, 2024 |
| BOOTHBAY FUND MANAGEMENT, LLC | 0.04% | 0.02% | 15,900 | 15,900 | 100.00% | 648,720 | Jun 30, 2024 |
| UBS OCONNOR LLC | 0.04% | 0.04% | 15,000 | 15,000 | 100.00% | 612,000 | Jun 30, 2024 |
| SG AMERICAS SECURITIES, LLC | 0.04% | 0.00% | 13,941 | 13,941 | 100.00% | 569,000 | Jun 30, 2024 |
| CINCTIVE CAPITAL MANAGEMENT LP | 0.04% | 0.03% | 13,190 | 13,190 | 100.00% | 538,152 | Jun 30, 2024 |
| NEOS INVESTMENT MANAGEMENT LLC | 0.04% | 0.02% | 12,950 | 12,950 | 100.00% | 528,360 | Jun 30, 2024 |
| COREBRIDGE FINANCIAL, INC. | 0.03% | 0.00% | 11,832 | 11,832 | 100.00% | 482,864 | Jun 30, 2024 |
| DEUTSCHE BANK AG\ | 0.03% | 0.00% | 9,469 | 9,469 | 100.00% | 386,335 | Jun 30, 2024 |
| VOYA INVESTMENT MANAGEMENT LLC | 0.02% | 0.00% | 7,364 | 7,364 | 100.00% | 300,451 | Jun 30, 2024 |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | 0.02% | 0.00% | 6,630 | 6,630 | 100.00% | 270,504 | Jun 30, 2024 |
| OMERS ADMINISTRATION CORP | 0.02% | 0.00% | 6,200 | 6,200 | 100.00% | 252,960 | Jun 30, 2024 |
| METLIFE INVESTMENT MANAGEMENT, LLC | 0.02% | 0.00% | 5,576 | 5,576 | 100.00% | 227,501 | Jun 30, 2024 |
| AMERITAS INVESTMENT PARTNERS, INC. | 0.01% | 0.00% | 2,155 | 2,155 | 100.00% | 87,924 | Jun 30, 2024 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 0.01% | 0.00% | 2,031 | 2,031 | 100.00% | 84,794 | Jun 30, 2024 |
| AQUATIC CAPITAL MANAGEMENT LLC | 0.00% | 0.00% | 900 | 900 | 100.00% | 36,720 | Jun 30, 2024 |
| AMALGAMATED BANK | 0.00% | 0.00% | 761 | 761 | 100.00% | 31,000 | Jun 30, 2024 |
| FMR LLC | - | - | 11 | 11 | 100.00% | 449 | Jun 30, 2024 |
| ALLWORTH FINANCIAL LP | - | - | 5 | 5 | 100.00% | 235 | Jun 30, 2024 |
| ROTHSCHILD INVESTMENT LLC | - | - | 5 | 5 | 100.00% | 204 | Jun 30, 2024 |
| QUANTBOT TECHNOLOGIES LP | - | - | 4 | 4 | 100.00% | 163 | Jun 30, 2024 |
Soleno Therapeutics's largest new institutional shareholder by number of shares is ASSENAGON ASSET MANAGEMENT S.A., purchased 729.84K shares, valued at $29.78M, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| MARSHALL WACE, LLP | - | - | - | -176,237 | -100.00% | - | Jun 30, 2024 |
| STEMPOINT CAPITAL LP | - | - | - | -115,833 | -100.00% | - | Jun 30, 2024 |
| IKARIAN CAPITAL, LLC | - | - | - | -81,100 | -100.00% | - | Jun 30, 2024 |
| EAM INVESTORS, LLC | - | - | - | -64,411 | -100.00% | - | Jun 30, 2024 |
| FARALLON CAPITAL MANAGEMENT LLC | - | - | - | -27,750 | -100.00% | - | Jun 30, 2024 |
| ALLIANZ ASSET MANAGEMENT GMBH | - | - | - | -25,100 | -100.00% | - | Jun 30, 2024 |
| BOOTHBAY FUND MANAGEMENT, LLC | - | - | - | -21,600 | -100.00% | - | Jun 30, 2024 |
| SQUAREPOINT OPS LLC | - | - | - | -14,580 | -100.00% | - | Jun 30, 2024 |
| EXODUSPOINT CAPITAL MANAGEMENT, LP | - | - | - | -14,206 | -100.00% | - | Jun 30, 2024 |
| CANNON GLOBAL INVESTMENT MANAGEMENT, LLC | - | - | - | -11,800 | -100.00% | - | Jun 30, 2024 |
| HIGHVISTA STRATEGIES LLC | - | - | - | -10,428 | -100.00% | - | Jun 30, 2024 |
| WOLVERINE TRADING, LLC | - | - | - | -7,200 | -100.00% | - | Jun 30, 2024 |
| POLYMER CAPITAL MANAGEMENT (HK) LTD | - | - | - | -6,914 | -100.00% | - | Jun 30, 2024 |
| LMR PARTNERS LLP | - | - | - | -6,830 | -100.00% | - | Jun 30, 2024 |
| AQR CAPITAL MANAGEMENT LLC | - | - | - | -6,792 | -100.00% | - | Jun 30, 2024 |
| E FUND MANAGEMENT CO., LTD. | - | - | - | -5,016 | -100.00% | - | Jun 30, 2024 |
| MACQUARIE GROUP LTD | - | - | - | -1,736 | -100.00% | - | Jun 30, 2024 |
| QUARRY LP | - | - | - | -1,650 | -100.00% | - | Jun 30, 2024 |
| ENTRYPOINT CAPITAL, LLC | - | - | - | -135 | -100.00% | - | Jun 30, 2024 |
| HARBOUR INVESTMENTS, INC. | - | - | - | -5 | -100.00% | - | Jun 30, 2024 |
Soleno Therapeutics's largest sold out institutional shareholder by shares sold is MARSHALL WACE, LLP, sold -0.18M shares, valued at -, as of undefined.
Soleno Therapeutics Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| QUANTITATIVE MASTER SERIES LLC | 0.02% | 105,332 | - | - | Mar 31, 2024 |
| DEUTSCHE DWS INVESTMENTS VIT FUNDS | 0.02% | 9,839 | - | - | Mar 31, 2024 |
| TIAA SEPARATE ACCOUNT VA 1 | 0.01% | 2,198 | - | - | Mar 31, 2024 |
| VANGUARD INDEX FUNDS | 0.00% | 1,950,152 | - | - | Mar 31, 2024 |
| JANUS INVESTMENT FUND | 0.00% | 1,161,785 | 189,612 | 19.50% | Dec 31, 2023 |
| SCHWAB CAPITAL TRUST | 0.00% | 123,492 | - | - | Feb 29, 2024 |
| VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 66,304 | - | - | Mar 31, 2024 |
| TIAA-CREF LIFE FUNDS | 0.00% | 5,525 | - | - | Mar 31, 2024 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 402,349 | - | - | Feb 29, 2024 |
| ETFis Series Trust I | 0.00% | 2,207 | 2,207 | - | Jan 31, 2024 |
| FINANCIAL INVESTORS TRUST | 0.00% | 107,983 | - | - | Jan 31, 2024 |
| Calvert Variable Products, Inc. | 0.00% | 2,954 | - | - | Mar 31, 2024 |
| SunAmerica Specialty Series | 0.00% | 491 | - | - | Apr 30, 2021 |
| Columbia Funds Variable Series Trust II | 0.00% | 29,288 | 29,288 | - | Mar 31, 2024 |
| Voya VARIABLE PORTFOLIOS INC | 0.00% | 28,835 | - | - | Mar 31, 2024 |
| BNY Mellon Strategic Funds, Inc. | 0.00% | 1,471 | 1,471 | - | Feb 29, 2024 |
| FIDELITY COVINGTON TRUST | 0.00% | 6,046 | 6,046 | - | Jan 31, 2024 |
| PENN SERIES FUNDS INC | 0.00% | 7,524 | -1,943 | -20.52% | Mar 28, 2024 |
| ALLSPRING MASTER TRUST | 0.00% | 15,887 | - | - | Feb 29, 2024 |
| NORTHERN FUNDS | 0.00% | 31,902 | - | - | Mar 28, 2024 |
| PGIM ETF TRUST | 0.00% | 12,512 | - | - | Feb 29, 2024 |
| SCHWAB CAPITAL TRUST | 0.00% | 7,195 | 7,195 | - | Jan 31, 2024 |
| STATE STREET INSTITUTIONAL INVESTMENT TRUST | 0.00% | 11,000 | - | - | Mar 31, 2024 |
| FIDELITY SALEM STREET TRUST | 0.00% | 517,907 | - | - | Mar 31, 2024 |
| HC CAPITAL TRUST | 0.00% | 3,995 | - | - | Mar 31, 2024 |
| ProFunds | 0.00% | 1,292 | - | - | Mar 31, 2024 |
| VALIC Co I | 0.00% | 28,273 | - | - | Feb 29, 2024 |
| VANGUARD SCOTTSDALE FUNDS | 0.00% | 189,525 | - | - | Feb 29, 2024 |
| PENN SERIES FUNDS INC | 0.00% | 2,600 | - | - | Mar 28, 2024 |
| NATIONWIDE VARIABLE INSURANCE TRUST | 0.00% | 11,408 | - | - | Mar 31, 2024 |
| Blackstone Alternative Investment Funds | 0.00% | 4,300 | - | - | Mar 31, 2023 |
| PACE SELECT ADVISORS TRUST | 0.00% | 20,106 | - | - | Jan 31, 2024 |
| TIAA-CREF FUNDS | 0.00% | 179,990 | - | - | Mar 31, 2024 |
| NATIONWIDE MUTUAL FUNDS | 0.00% | 7,175 | - | - | Jan 31, 2024 |
| COLLEGE RETIREMENT EQUITIES FUND | 0.00% | 42,474 | - | - | Mar 31, 2024 |
| USAA MUTUAL FUNDS TRUST | 0.00% | 7,663 | - | - | Jan 31, 2024 |
| T. Rowe Price Index Trust, Inc. | 0.00% | 603 | - | - | Feb 29, 2024 |
| MORGAN STANLEY PATHWAY FUNDS | 0.00% | 2,415 | - | - | Feb 29, 2024 |
| SUNAMERICA SERIES TRUST | 0.00% | 6,442 | - | - | Mar 31, 2024 |
| DFA INVESTMENT DIMENSIONS GROUP INC | 0.00% | 15,466 | - | - | Jan 31, 2024 |
| Dimensional ETF Trust | 0.00% | 5,288 | - | - | Jan 31, 2024 |
| PRINCIPAL FUNDS, INC. | 0.00% | 70,696 | - | - | Jan 31, 2024 |
| USAA MUTUAL FUNDS TRUST | 0.00% | 2,433 | 1,544 | 173.68% | Jan 31, 2024 |
| EQ ADVISORS TRUST | 0.00% | 11,459 | - | - | Mar 31, 2024 |
| SEI INSTITUTIONAL MANAGED TRUST | 0.00% | 26,578 | -6,522 | -19.70% | Dec 31, 2023 |
| ADVANCED SERIES TRUST | 0.00% | 28,393 | 5,746 | 25.37% | Mar 28, 2024 |
| EXCHANGE TRADED CONCEPTS TRUST | 0.00% | 46 | - | - | Feb 29, 2024 |
| JOHN HANCOCK VARIABLE INSURANCE TRUST | 0.00% | 18,275 | - | - | Mar 31, 2024 |
| PACIFIC SELECT FUND | 0.00% | 26,716 | - | - | Mar 31, 2024 |
| MASSMUTUAL SELECT FUNDS | 0.00% | 7,093 | - | - | Dec 31, 2023 |
| Pacer Funds Trust | 0.00% | 283 | 283 | - | Jan 31, 2024 |
| NATIONWIDE MUTUAL FUNDS | 0.00% | 631 | 631 | - | Jan 31, 2024 |
| Bridge Builder Trust | 0.00% | 21,044 | - | - | Mar 31, 2024 |
| JOHN HANCOCK VARIABLE INSURANCE TRUST | 0.00% | 5,133 | 5,133 | - | Mar 31, 2024 |
| BlackRock Variable Series Funds, Inc. | 0.00% | 7,871 | - | - | Mar 31, 2024 |
| PRINCIPAL FUNDS, INC. | 0.00% | 9,877 | - | - | Feb 29, 2024 |
| John Hancock Funds II | 0.00% | 10,297 | - | - | Feb 29, 2024 |
| John Hancock Funds II | 0.00% | 6,181 | 6,181 | - | Feb 29, 2024 |
| BLACKROCK FUNDS | 0.00% | 2,648 | - | - | Mar 28, 2024 |
| Advisors' Inner Circle Fund III | 0.00% | 31 | - | - | Jan 31, 2024 |
Soleno Therapeutics's largest mutual fund holder by % of total assets is "QUANTITATIVE MASTER SERIES LLC", owning 105.33K shares, compromising 0.02% of its total assets.
Soleno Therapeutics Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 30 Jun, 24 | 119 | 10.19% |
| 31 Mar, 24 | 108 | 28.57% |
| 31 Dec, 23 | 84 | 55.56% |
| 30 Sep, 23 | 54 | 145.45% |
| 30 Jun, 23 | 22 | 10.00% |
| 31 Mar, 23 | 20 | -13.04% |
| 31 Dec, 22 | 23 | 27.78% |
| 30 Sep, 22 | 18 | -50.00% |
| 30 Jun, 22 | 36 | - |
| 31 Mar, 22 | 36 | -5.26% |
| 31 Dec, 21 | 38 | -2.56% |
| 30 Sep, 21 | 39 | -25.00% |
| 30 Jun, 21 | 52 | -21.21% |
| 31 Mar, 21 | 66 | -4.35% |
| 31 Dec, 20 | 69 | 4.55% |
| 30 Sep, 20 | 66 | -9.59% |
| 30 Jun, 20 | 73 | 135.48% |
| 31 Mar, 20 | 31 | 63.16% |
| 31 Dec, 19 | 19 | 11.76% |
| 30 Sep, 19 | 17 | -5.56% |
| 30 Jun, 19 | 18 | -10.00% |
| 31 Mar, 19 | 20 | 25.00% |
| 31 Dec, 18 | 16 | 14.29% |
| 30 Sep, 18 | 14 | -12.50% |
| 30 Jun, 18 | 16 | 100.00% |
| 31 Mar, 18 | 8 | -11.11% |
| 31 Dec, 17 | 9 | - |
As of 30 Jun 24, 119 institutions are holding Soleno Therapeutics's shares, representing an increase of 10.19% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 30 Jun, 24 | 43,316,980 | 21.90% |
| 31 Mar, 24 | 35,536,015 | 13.14% |
| 31 Dec, 23 | 31,409,972 | 54.72% |
| 30 Sep, 23 | 20,301,195 | 318.35% |
| 30 Jun, 23 | 4,852,710 | 57.98% |
| 31 Mar, 23 | 3,071,643 | 10.25% |
| 31 Dec, 22 | 2,785,956 | -3.41% |
| 30 Sep, 22 | 2,884,276 | -93.60% |
| 30 Jun, 22 | 45,033,127 | -3.95% |
| 31 Mar, 22 | 46,885,482 | 67.51% |
| 31 Dec, 21 | 27,989,875 | -1.73% |
| 30 Sep, 21 | 28,482,181 | -0.75% |
| 30 Jun, 21 | 28,696,893 | -9.75% |
| 31 Mar, 21 | 31,798,098 | -24.83% |
| 31 Dec, 20 | 42,303,989 | 1.42% |
| 30 Sep, 20 | 41,711,480 | 1.83% |
| 30 Jun, 20 | 40,959,917 | 99.21% |
| 31 Mar, 20 | 20,561,372 | 19.38% |
| 31 Dec, 19 | 17,223,998 | 71.18% |
| 30 Sep, 19 | 10,062,024 | -30.11% |
| 30 Jun, 19 | 14,396,615 | -0.01% |
| 31 Mar, 19 | 14,397,730 | -2.74% |
| 31 Dec, 18 | 14,803,113 | 67.28% |
| 30 Sep, 18 | 8,849,455 | 0.60% |
| 30 Jun, 18 | 8,796,506 | 5.09% |
| 31 Mar, 18 | 8,370,203 | 1.14% |
| 31 Dec, 17 | 8,275,469 | - |
Soleno Therapeutics (SLNO) has 43.32M shares outstanding as of 30 Jun 24, up 21.90% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 30 Jun, 24 | 119.63% | 1.24% |
| 31 Mar, 24 | 98.14% | 1.18% |
| 31 Dec, 23 | 91.34% | 2.62% |
| 30 Sep, 23 | 59.04% | 29.65% |
| 30 Jun, 23 | 14.11% | 17.69% |
| 31 Mar, 23 | 8.93% | 13.61% |
| 31 Dec, 22 | 8.10% | 11.52% |
| 30 Sep, 22 | 8.39% | 0.05% |
| 30 Jun, 22 | 130.96% | 0.70% |
| 31 Mar, 22 | 136.34% | 2.06% |
| 31 Dec, 21 | 81.39% | 1.19% |
| 30 Sep, 21 | 82.83% | 1.19% |
| 30 Jun, 21 | 83.45% | 0.98% |
| 31 Mar, 21 | 92.47% | 0.61% |
| 31 Dec, 20 | 123.02% | 0.84% |
| 30 Sep, 20 | 121.30% | 0.85% |
| 30 Jun, 20 | 119.11% | 3.33% |
| 31 Mar, 20 | 59.79% | 2.38% |
| 31 Dec, 19 | 50.09% | 5.85% |
| 30 Sep, 19 | 29.26% | 1.67% |
| 30 Jun, 19 | 41.87% | 2.39% |
| 31 Mar, 19 | 41.87% | 2.26% |
| 31 Dec, 18 | 43.05% | 6.50% |
| 30 Sep, 18 | 25.73% | 3.93% |
| 30 Jun, 18 | 25.58% | 4.32% |
| 31 Mar, 18 | 24.34% | 4.20% |
| 31 Dec, 17 | 24.07% | - |
As of 30 Jun 24, Soleno Therapeutics is held by 119.63% institutional shareholders, representing a 1.24% growth compared to 31 Mar 24.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 79 | 3.95% |
| 31 Mar, 24 | 76 | 35.71% |
| 31 Dec, 23 | 56 | 33.33% |
| 30 Sep, 23 | 42 | 600.00% |
| 30 Jun, 23 | 6 | -33.33% |
| 31 Mar, 23 | 9 | -18.18% |
| 31 Dec, 22 | 11 | 266.67% |
| 30 Sep, 22 | 3 | -72.73% |
| 30 Jun, 22 | 11 | -15.38% |
| 31 Mar, 22 | 13 | 8.33% |
| 31 Dec, 21 | 12 | -7.69% |
| 30 Sep, 21 | 13 | -38.10% |
| 30 Jun, 21 | 21 | -22.22% |
| 31 Mar, 21 | 27 | -15.63% |
| 31 Dec, 20 | 32 | -13.51% |
| 30 Sep, 20 | 37 | -38.33% |
| 30 Jun, 20 | 60 | 200.00% |
| 31 Mar, 20 | 20 | 66.67% |
| 31 Dec, 19 | 12 | 20.00% |
| 30 Sep, 19 | 10 | 25.00% |
| 30 Jun, 19 | 8 | -33.33% |
| 31 Mar, 19 | 12 | 50.00% |
| 31 Dec, 18 | 8 | - |
| 30 Sep, 18 | 8 | -42.86% |
| 30 Jun, 18 | 14 | 250.00% |
| 31 Mar, 18 | 4 | -55.56% |
| 31 Dec, 17 | 9 | - |
79 institutional shareholders have increased their position in SLNO stock as of 30 Jun 24 compared to 76 in the previous quarter (a 3.95% increase).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 25 | 66.67% |
| 31 Mar, 24 | 15 | 15.38% |
| 31 Dec, 23 | 13 | 62.50% |
| 30 Sep, 23 | 8 | - |
| 30 Jun, 23 | 8 | 300.00% |
| 31 Mar, 23 | 2 | -66.67% |
| 31 Dec, 22 | 6 | -53.85% |
| 30 Sep, 22 | 13 | 18.18% |
| 30 Jun, 22 | 11 | - |
| 31 Mar, 22 | 11 | 83.33% |
| 31 Dec, 21 | 6 | -25.00% |
| 30 Sep, 21 | 8 | -55.56% |
| 30 Jun, 21 | 18 | -14.29% |
| 31 Mar, 21 | 21 | - |
| 31 Dec, 20 | 21 | 61.54% |
| 30 Sep, 20 | 13 | 160.00% |
| 30 Jun, 20 | 5 | 25.00% |
| 31 Mar, 20 | 4 | -20.00% |
| 31 Dec, 19 | 5 | 66.67% |
| 30 Sep, 19 | 3 | -40.00% |
| 30 Jun, 19 | 5 | 66.67% |
| 31 Mar, 19 | 3 | - |
| 31 Dec, 18 | 3 | 200.00% |
| 30 Sep, 18 | 1 | - |
| 30 Jun, 18 | 1 | - |
| 31 Mar, 18 | 1 | - |
| 31 Dec, 17 | - | - |
25 institutional shareholders have reduced their position in SLNO stock as of 30 Jun 24 compared to 15 in the previous quarter (a 66.67% increase).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 30 Jun, 24 | 119 | 10.19% | 43,316,980 | 21.90% | 119.63% | 1.24% | 79 | 3.95% | 25 | 66.67% |
| 31 Mar, 24 | 108 | 28.57% | 35,536,015 | 13.14% | 98.14% | 1.18% | 76 | 35.71% | 15 | 15.38% |
| 31 Dec, 23 | 84 | 55.56% | 31,409,972 | 54.72% | 91.34% | 2.62% | 56 | 33.33% | 13 | 62.50% |
| 30 Sep, 23 | 54 | 145.45% | 20,301,195 | 318.35% | 59.04% | 29.65% | 42 | 600.00% | 8 | - |
| 30 Jun, 23 | 22 | 10.00% | 4,852,710 | 57.98% | 14.11% | 17.69% | 6 | -33.33% | 8 | 300.00% |
| 31 Mar, 23 | 20 | -13.04% | 3,071,643 | 10.25% | 8.93% | 13.61% | 9 | -18.18% | 2 | -66.67% |
| 31 Dec, 22 | 23 | 27.78% | 2,785,956 | -3.41% | 8.10% | 11.52% | 11 | 266.67% | 6 | -53.85% |
| 30 Sep, 22 | 18 | -50.00% | 2,884,276 | -93.60% | 8.39% | 0.05% | 3 | -72.73% | 13 | 18.18% |
| 30 Jun, 22 | 36 | - | 45,033,127 | -3.95% | 130.96% | 0.70% | 11 | -15.38% | 11 | - |
| 31 Mar, 22 | 36 | -5.26% | 46,885,482 | 67.51% | 136.34% | 2.06% | 13 | 8.33% | 11 | 83.33% |
| 31 Dec, 21 | 38 | -2.56% | 27,989,875 | -1.73% | 81.39% | 1.19% | 12 | -7.69% | 6 | -25.00% |
| 30 Sep, 21 | 39 | -25.00% | 28,482,181 | -0.75% | 82.83% | 1.19% | 13 | -38.10% | 8 | -55.56% |
| 30 Jun, 21 | 52 | -21.21% | 28,696,893 | -9.75% | 83.45% | 0.98% | 21 | -22.22% | 18 | -14.29% |
| 31 Mar, 21 | 66 | -4.35% | 31,798,098 | -24.83% | 92.47% | 0.61% | 27 | -15.63% | 21 | - |
| 31 Dec, 20 | 69 | 4.55% | 42,303,989 | 1.42% | 123.02% | 0.84% | 32 | -13.51% | 21 | 61.54% |
| 30 Sep, 20 | 66 | -9.59% | 41,711,480 | 1.83% | 121.30% | 0.85% | 37 | -38.33% | 13 | 160.00% |
| 30 Jun, 20 | 73 | 135.48% | 40,959,917 | 99.21% | 119.11% | 3.33% | 60 | 200.00% | 5 | 25.00% |
| 31 Mar, 20 | 31 | 63.16% | 20,561,372 | 19.38% | 59.79% | 2.38% | 20 | 66.67% | 4 | -20.00% |
| 31 Dec, 19 | 19 | 11.76% | 17,223,998 | 71.18% | 50.09% | 5.85% | 12 | 20.00% | 5 | 66.67% |
| 30 Sep, 19 | 17 | -5.56% | 10,062,024 | -30.11% | 29.26% | 1.67% | 10 | 25.00% | 3 | -40.00% |
| 30 Jun, 19 | 18 | -10.00% | 14,396,615 | -0.01% | 41.87% | 2.39% | 8 | -33.33% | 5 | 66.67% |
| 31 Mar, 19 | 20 | 25.00% | 14,397,730 | -2.74% | 41.87% | 2.26% | 12 | 50.00% | 3 | - |
| 31 Dec, 18 | 16 | 14.29% | 14,803,113 | 67.28% | 43.05% | 6.50% | 8 | - | 3 | 200.00% |
| 30 Sep, 18 | 14 | -12.50% | 8,849,455 | 0.60% | 25.73% | 3.93% | 8 | -42.86% | 1 | - |
| 30 Jun, 18 | 16 | 100.00% | 8,796,506 | 5.09% | 25.58% | 4.32% | 14 | 250.00% | 1 | - |
| 31 Mar, 18 | 8 | -11.11% | 8,370,203 | 1.14% | 24.34% | 4.20% | 4 | -55.56% | 1 | - |
| 31 Dec, 17 | 9 | - | 8,275,469 | - | 24.07% | - | 9 | - | - | - |
Soleno Therapeutics Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Insider Sells
All Insider Owners Trades
The last insider sell of Soleno Therapeutics's stock was made by Yen Kristen on Aug 07 2024, selling 2,826 shares at $45.48 per share (valued at $128.52K).
Soleno Therapeutics Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2024 | 7 | 28 | 25.00% |
| Q2 2024 | 6 | 13 | 46.15% |
| Q1 2024 | 8 | 4 | 200.00% |
| Q4 2023 | 10 | 42 | 23.81% |
| Q3 2023 | 20 | 2 | 1000.00% |
| Q2 2023 | 36 | - | - |
| Q1 2023 | 4 | - | - |
| Q4 2022 | - | 31 | - |
| Q3 2022 | 7 | 18 | 38.89% |
| Q2 2022 | 5 | - | - |
| Q1 2022 | 22 | 3 | 733.33% |
| Q4 2021 | 3 | 1 | 300.00% |
| Q3 2021 | 4 | 5 | 80.00% |
| Q2 2021 | 11 | 7 | 157.14% |
| Q1 2021 | 12 | 22 | 54.55% |
| Q4 2020 | 4 | 6 | 66.67% |
| Q3 2020 | 4 | - | - |
| Q2 2020 | 19 | 2 | 950.00% |
| Q1 2020 | 8 | - | - |
| Q4 2019 | 5 | 18 | 27.78% |
7 total buy trades, and 28 total sell trades (buy/sell ratio of 0.25%) were made by Soleno Therapeutics's insiders, as of Q3 2024.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2024 | - | 28 | - |
| Q2 2024 | - | 10 | - |
| Q1 2024 | - | 3 | - |
| Q4 2023 | - | 31 | - |
| Q3 2023 | 16 | - | - |
| Q2 2023 | 14 | - | - |
| Q1 2023 | - | - | - |
| Q4 2022 | - | 31 | - |
| Q3 2022 | - | 18 | - |
| Q2 2022 | - | - | - |
| Q1 2022 | 15 | 2 | 750.00% |
| Q4 2021 | - | - | - |
| Q3 2021 | 1 | 4 | 25.00% |
| Q2 2021 | - | 6 | - |
| Q1 2021 | - | 15 | - |
| Q4 2020 | - | 6 | - |
| Q3 2020 | - | - | - |
| Q2 2020 | 6 | 2 | 300.00% |
| Q1 2020 | - | - | - |
| Q4 2019 | 5 | 18 | 27.78% |
As of Q3 2024, Insider owners conducted 0 open market buy trades and 28 open market sell trades of Soleno Therapeutics's stocks.
Soleno Therapeutics Peer Ownership
| Ticker | Company |
|---|---|
| XFOR | X4 Pharmaceuticals, Inc. |
| VECT | VectivBio Holding AG |
| PULM | Pulmatrix, Inc. |
| DAWN | Day One Biopharmaceuticals, Inc. |
| BPTH | Bio-Path Holdings, Inc. |
| CAPR | Capricor Therapeutics, Inc. |
| DFFN | CervoMed Inc. |
| AKTX | Akari Therapeutics, Plc |
| BOLT | Bolt Biotherapeutics, Inc. |
| INZY | Inozyme Pharma, Inc. |
| ANNX | Annexon, Inc. |
| ABOS | Acumen Pharmaceuticals, Inc. |
| MBRX | Moleculin Biotech, Inc. |
| ONTX | Traws Pharma, Inc. |
| LYRA | Lyra Therapeutics, Inc. |
| CBIO | Gyre Therapeutics, Inc. |
| BNTC | Benitec Biopharma Inc. |
| ALRN | Aileron Therapeutics, Inc. |
SLNO Ownership FAQ
Who Owns Soleno Therapeutics?
Soleno Therapeutics is owned by institutional shareholders (119.63%), insiders (3.38%), and public (-23.01%). The largest institutional shareholder of Soleno Therapeutics is VIVO CAPITAL, LLC (20.21% of total shares) and the top mutual fund owner is QUANTITATIVE MASTER SERIES LLC (0.02% of total shares).
Who are the major institutional shareholders of Soleno Therapeutics?
Soleno Therapeutics's major institutional shareholders are VIVO CAPITAL, LLC, CARLYLE GROUP INC., JANUS HENDERSON GROUP PLC, PERCEPTIVE ADVISORS LLC, and NANTAHALA CAPITAL MANAGEMENT, LLC. The top five shareholders own together 58.09% of the company's share outstanding.
How many Soleno Therapeutics shareholders are there?
As of Jun 2024, there are 119 institutional shareholders of Soleno Therapeutics.
What percentage of Soleno Therapeutics is owned by VIVO CAPITAL, LLC?
VIVO CAPITAL, LLC owns 7.32M shares of Soleno Therapeutics, representing 20.21% of the company's total shares outstanding, valued at $298.53M (as of Jun 2024).
What percentage of Soleno Therapeutics is owned by CARLYLE GROUP INC?
As of Jun 2024, CARLYLE GROUP INC holds 4.07M shares of Soleno Therapeutics (SLNO), compromising 11.24% of the company, valued at $166.36M.
What percentage of Soleno Therapeutics is owned by JANUS HENDERSON GROUP PLC?
JANUS HENDERSON GROUP PLC is the third largest holder of Soleno Therapeutics. The company owns 3.36M of the company's shares outstanding (worth $137.14M).